Mexico Tourism

Showing 130 articles
Business

Idorsia's Latin American Gambit: QUVIVIQ Deal with EMS Signals Strategic Shift Amid Pipeline Scrutiny

Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.

Business

First Hawaiian Bank's Valuation Under Scrutiny Amid Volatile Trading

First Hawaiian Bank (FHB) shares have captured investor interest following a period of mixed performance, trading at $26.55. While recent daily declines contrast with solid monthly and quarterly gains, analysts debate whether the stock's current discount to intrinsic value represents a buying opportunity or reflects underlying economic risks.

Business

Osisko Development Secures $125M for Cariboo Gold Project Amid Operational Pause and Valuation Debate

Osisko Development Corp. (TSXV:ODV) has announced a major $125 million equity financing to advance its flagship Cariboo Gold Project in British Columbia, following a temporary operational suspension due to a contractor fatality. The move comes as the company's shares show strong recent momentum but trade at a significant discount to peers, raising questions about its valuation and path forward.